Founded in 1998 by Edwin Cohen, former Chairman and CEO of Barr Laboratories, Intranasal Therapeutics (ITI) focuses on developing nasally delivered pharmaceutical products, with a particular emphasis on drugs for pain and central nervous system disorders. ITI is dedicated to creating nasal spray drug products and is part of the Ikano Therapeutics Inc. family, which is also a specialty pharmaceutical company specializing in nasal spray drug development.